British surgeon Ara Darzi told the WIRED Health conference that artificial intelligence is set to revolutionize the diagnosis and treatment of drug-resistant infections. He cautioned that insufficient incentives might block these innovations from reaching patients. Antibiotic resistance already causes over a million deaths worldwide each year.
Ara Darzi, a British surgeon, addressed attendees at WIRED Health, emphasizing AI's potential to tackle one of the world's most pressing health threats. 'AI is set to transform the diagnosis and treatment of drug-resistant infections,' Darzi said, as first reported by WIRED on April 29, 2026. He highlighted how such technology could address the growing crisis more effectively than current methods alone. Antibiotic resistance has emerged as a fast-growing public health emergency. It directly causes more than one million global deaths annually and contributes to nearly five million additional fatalities. These superbug infections prove harder to treat and far more costly, leading to extended hospital stays that burden both healthcare systems and patients. Darzi pointed to a key barrier: a lack of incentives for innovation. Without proper motivation, breakthroughs in AI-driven solutions risk remaining confined to labs rather than entering clinical practice. Hospitals face rising expenses from prolonged treatments, underscoring the urgency for new approaches.
